The impact of dendritic cells on angiogenic responses at the fetal-maternal interface

Journal of Reproductive Immunology

Volumn 83, Issue 1-2, 2009, Pages 85-94

  Barrientos, G ^a   Tirado Gonzalez I ^a   Klapp, B F ^a   Karimi, K ^b   Arck, P C ^a,b   Garcia, M G ^a,c   Blois, S M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

Angiogenesis; Dendritic cells; Natural killer cells; Pregnancy; VEGF

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; PLACENTAL GROWTH FACTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CYTOKINE PRODUCTION; DECIDUA; DENDRITIC CELL; EMBRYO GROWTH; EMBRYO RESORPTION; ENDOMETRIOSIS; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; FETUS GROWTH; HUMAN; IMMUNOLOGICAL TOLERANCE; NATURAL KILLER CELL; NIDATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TROPHOBLAST;

DECIDUA; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; MATERNAL-FETAL EXCHANGE; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTAL CIRCULATION; PREGNANCY;

EID: 70449712546     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.07.011     Document Type: Review

References (55)

1. Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9 (2003) 936-943
2. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 13 (2007) 1450-1457
3. Blois S.M., Kammerer U., Alba Soto C., Tometten M.C., Shaikly V., Barrientos G., et al. Dendritic cells: key to fetal tolerance?. Biol. Reprod. 77 (2007) 590-598
4. Blois S.M., Barrientos G., Garcia M.G., Orsal A.S., Tometten M., Cordo-Russo R.I., et al. Interaction between dendritic cells and natural killer cells during pregnancy in mice. J. Mol. Med. 86 (2008) 837-852
5. Chantakru S., Miller C., Roach L.E., Kuziel W.A., Maeda N., Wang W.C., et al. Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J. Immunol. 168 (2002) 22-28
6. Chen W.S., Kitson R.P., and Goldfarb R.H. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). In Vivo 16 (2002) 439-445
7. Chung I.B., Yelian F.D., Zaher F.M., Gonik B., Evans M.I., Diamond M.P., et al. Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. Placenta 21 (2000) 320-324
8. Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10 (2004) 950-958
9. Conejo-Garcia J.R., Buckanovich R.J., Benencia F., Courreges M.C., Rubin S.C., Carroll R.G., et al. Vascular leukocytes contribute to tumor vascularization. Blood 105 (2005) 679-681
10. Cross J.C., Hemberger M., Lu Y., Nozaki T., Whiteley K., Masutani M., et al. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol. Cell. Endocrinol. 187 (2002) 207-212
11. Croy B.A., Esadeg S., Chantakru S., van den Heuvel M., Paffaro V.A., He H., et al. Update on pathways regulating the activation of uterine natural killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J. Reprod. Immunol. 59 (2003) 175-191
12. Curiel T.J., Cheng P., Mottram P., Alvarez X., Moons L., Evdemon-Hogan M., et al. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res. 64 (2004) 5535-5538
13. Distler J.H., Hirth A., Kurowska-Stolarska M., Gay R.E., Gay S., and Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q. J. Nucl. Med. 47 (2003) 149-161
14. Fainaru O., Adini A., Benny O., Adini I., Short S., Bazinet L., et al. Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. FASEB J. 22 (2008) 522-529
15. Fernandez Pujol B., Lucibello F.C., Zuzarte M., Lütjens P., Müller R., and Havemann K. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur. J. Cell Biol. 80 (2001) 99-110
16. Ghosh D., Sharkey A.M., Charnock-Jones D.S., Dhawan L., Dhara S., Smith S.K., et al. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey. Mol. Hum. Reprod. 6 (2000) 935-941
17. Girardi G., Yarilin D., Thurman J.M., Holers V.M., and Salmon J.E. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 203 (2006) 2165-2175
18. Halder J.B., Zhao X., Soker S., Paria B.C., Klagsbrun M., Das S.K., et al. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis 26 (2000) 213-224
19. Hanna J., Wald O., Goldman-Wohl D., Prus D., Markel G., Gazit R., et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16-human natural killer cells. Blood 102 (2003) 1569-1577
20. Hess A.P., Hamilton A.E., Talbi S., Dosiou C., Nyegaard M., Nayak N., et al. Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol. Reprod. 76 (2007) 102-117
21. Hyder S.M., and Stancel G.M. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol. Endocrinol. 13 (1999) 806-811
22. Kalkunte S., Chichester C.O., Gotsch F., Sentman C.L., Romero R., and Sharma S. Evolution of non-cytotoxic uterine natural killer cells. Am. J. Reprod. Immunol. 59 (2008) 425-433
23. Kammerer U., Kruse A., Barrientos G., Arck P.C., and Blois S.M. Role of dendritic cells in the regulation of maternal immune responses to the fetus during mammalian gestation. Immunol. Invest. 37 (2008) 499-533
24. Kämmerer U., Eggert A.O., Kapp M., McLellan A.D., Geijtenbeek T.B., Dietl J., et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 162 (2003) 887-896
25. Klauber N., Rohan R.M., Flynn E., and D'Amato R.J. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat. Med. 3 (1997) 443-446
26. Krey G., Frank P., Shaikly V., Barrientos G., Cordo-Russo R., Ringel F., et al. In vivo dendritic cell depletion reduces breeding efficiency, affecting implantation and early placental development in mice. J. Mol. Med. 86 (2008) 999-1011
27. Leonard S., Murrant C., Tayade C., van den Heuvel M., Watering R., and Croy B.A. Mechanisms regulating immune cell contributions to spiral artery modification-facts and hypotheses: a review. Placenta 27 (2006) S40-S46
28. Lijnen H.R., Christiaens V., Scroyen I., Voros G., Tjwa M., Carmeliet P., et al. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55 (2006) 2698-2704
29. Lin Y.J., Lai M.D., Lei H.Y., and Wing L.Y. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 147 (2006) 1278-1286
30. Ma G.T., Roth M.E., Groskopf J.C., Tsai F.Y., Orkin S.H., Grosveld F., et al. GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. Development 124 (1997) 907-914
31. Meisser A., Cameo P., Islami D., Campana A., and Bischof P. Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Mol. Hum. Reprod. 5 (1999) 1055-1058
32. Miles S.A., Rezai A.R., Salazar-González J.F., Vander Meyden M., Stevens R.H., Logan D.M., et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4068-4072
33. Motro B., Itin A., Sachs L., and Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3092-3096
34. Nagamatsu T., Fujii T., Kusumi M., Zou L., Yamashita T., Osuga Y., et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145 (2004) 4838-4845
35. Piqueras B., Connolly J., Freitas H., Palucka A.K., and Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107 (2006) 2613-2618
36. Plaks V., Birnberg T., Berkutzki T., Sela S., BenYashar A., Kalchenko V., et al. Uterine DCs are crucial for decidua formation during embryo implantation in mice. J. Clin. Invest. 118 (2008) 3954-3965
37. Podor T.J., Jirik F.R., Loskutoff D.J., Carson D.A., and Lotz M. Human endothelial cells produce IL-6. Lack of responses to exogenous IL-6. Ann. N. Y. Acad. Sci. 557 (1989) 374-385
38. Polverini P.J. The pathophysiology of angiogenesis. Crit. Rev. Oral. Biol. Med. 6 (1995) 230-247
39. Relf M., LeJeune S., Scott P.A., Fox S., Smith K., Leek R., et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57 (1997) 963-969
40. Reynolds L.P., Caton J.S., Redmer D.A., Grazul-Bilska A.T., Vonnahme K.A., Borowicz P.P., et al. Evidence for altered placental blood flow and vascularity in compromised pregnancies. J. Physiol. 572 (2006) 51-58
41. Riboldi E., Musso T., Moroni E., Urbinati C., Bernasconi S., Rusnati M., et al. Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J. Immunol. 175 (2005) 2788-2792
42. Rosen E.M., Liu D., Setter E., Bhargava M., and Goldberg I.D. Interleukin-6 stimulates motility of vascular endothelium. EXS 59 (1991) 194-205
43. Rusnati M., and Presta M. Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. Endothelium 13 (2006) 93-111
44. Scholz C., Toth B., Santoso L., Kuhn C., Franz M., Mayr D., et al. Distribution and maturity of dendritic cells in diseases of insufficient placentation. Am. J. Reprod. Immunol. 60 (2008) 238-245
45. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
46. Srivastava R.K., Gu Y., Ayloo S., Zilberstein M., and Gibori G. Developmental expression and regulation of basic fibroblast growth factor and vascular endothelial growth factor in rat decidua and in a decidual cell line. J. Mol. Endocrinol. 21 (1998) 355-362
47. Szukiewicz D., Szewczyk G., Watroba M., Kurowska E., and Maslinski S. Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecol. Obstet. Invest. 59 (2005) 102-107
48. Tayade C., Fang Y., Hilchie D., and Croy B.A. Lymphocyte contributions to altered endometrial angiogenesis during early and midgestation fetal loss. J. Leukoc. Biol. 82 (2007) 877-886
49. Thijssen V.L., Postel R., Brandwijk R.J., Dings R.P., Nesmelova I., Satijn S., et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15975-15980
50. Tidwell S.C., Ho H.N., Chiu W.H., Torry R.J., and Torry D.S. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am. J. Obstet. Gynecol. 184 (2001) 1267-1272
51. Trinchieri G., Pflanz S., and Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19 (2003) 641-644
52. van den Heuvel M.J., Chantakru S., Xuemei X., Evans S.S., Tekpetey F., Mote P.A., et al. Trafficking of circulating pro-NK cells to the decidualizing uterus: regulatory mechanisms in the mouse and human. Immunol. Invest. 34 (2005) 273-293
53. Verhasselt V., Buelens C., Willems F., De Groote D., Haeffner-Cavaillon N., and Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 158 (1997) 2919-2925
54. Wei L.H., Kuo M.L., Chen C.A., Chou C.H., Lai K.B., Lee C.N., et al. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22 (2003) 1517-1527
55. Wei P., Chen X.L., Song X.X., Han C.S., and Liu Y.X. VEGF, bFGF, and their receptors in the endometrium of rhesus monkey during menstrual cycle and early pregnancy. Mol. Reprod. Dev. 68 (2004) 456-462